EP3302483
Lyfjasamsetningar og notkun þeirra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.5.2016EP published:
15.4.2020EP application number:
16799287.4
EP translation filed:
10.6.2020Grant published:
15.7.2020EPO information:
European Patent Register
Max expiry date:
23.5.2036Expiry date:
23.5.2026Next due date:
31.5.2026
Title:
PHARMACEUTICAL COMPOSITIONS AND USE THEREOF
Timeline
Today
24.5.2016EP application
15.4.2020EP Publication
10.6.2020Translation submitted
15.7.2020Registration published
23.5.2026Expires
Owner
Name:
Hutchison Medipharma LimitedAddress:
Building 4, 720 Cailun Road Hi-tech Park, Shanghai 201203, CN
Inventor
Name:
LIU, ZhongzhouAddress:
Shanghai 201203, CN
Name:
FU, ChongdongAddress:
Shanghai 201203, CN
Name:
SHI, BinAddress:
Shanghai 201203, CN
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/CN2015/079650Date:
25.5.2015Country:
WO
Classification
Categories:
A61K 9/16, A61K 9/20, A61K 31/506, A61P 35/00, A61K 9/48, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 2.6.2020
Expires: 23.5.2021
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 3.5.2021
Expires: 23.5.2022
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 3.5.2022
Expires: 23.5.2023
Payer: Patice ehf.
Number: 8
Paid: 23.5.2023
Expires: 23.5.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 2.5.2024
Expires: 23.5.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 16.5.2025
Expires: 23.5.2026
Payer: Árnason Faktor ehf.